Alvotech (ALVO) revenue breakdown

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $1.6B

By region, Europe is the largest at 52% of fiscal 2025 revenue; USA grew fastest, 138% a year over 3 years.

Revenue by region

Fiscal years, as Alvotech reports them in its 10-K filings; fiscal 2025 total $586M.

Regions202020212022202320242025Share
Europe$20M$21M$39M$64M$158M$307M 52%
USA——$18M$9M$273M$241M 41%
Rest of World——$26M$18M$59M$38M 6%
North America$38M$12M———— —
Other Geographical Area$5M————— —
Asia and Other—$5M———— —
Asia$4M————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALVO.
Open ALVO in Investingly

Questions

Where does Alvotech make its money?

In fiscal 2025, by region: Europe $307M, USA $241M, Rest of World $38M.

From Alvotech's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.